Pacira BioSciences PCRX
NASDAQ PCRX
$25.21 +0.20 (+0.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pacira BioSciences (PCRX) Cash & Current Investments (2010 - 2026)

Updated

Pacira BioSciences (PCRX) posted Cash & Current Investments of $251.03 million for Q2 2026, down 43.7% from $445.86 million a year earlier but up 24.2% from the prior quarter.

Analysis

Pacira BioSciences (PCRX) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Pacira BioSciences' Cash & Current Investments came in at $238.42 million, down 50.8% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of -14.5% (FY2020 to FY2025).
  • In prior years, Pacira BioSciences' Cash & Current Investments was $484.62 million in FY2024 (+74.0%), $278.58 million in FY2023 (-3.5%), $288.65 million in FY2022 (-56.0%) and $656.41 million in FY2021 (+25.8%).
  • Quarterly Cash & Current Investments has run from a low of $174 million in Q1 2023 to a high of $693.86 million in Q3 2021 over five years.
  • On a year-over-year basis, Cash & Current Investments has declined in each of the last four quarters, with growth averaging 3.7% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q3 2024, with growth of 93.0%; the weakest was Q1 2023, with a decline of 61.5%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $202.18 million (Q1 2026), $238.42 million (Q4 2025) and $246.33 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Pacira BioSciences 1.00 Bn 65.95 Mn 148.24 Mn 251.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 251.03 Mn
Mar 31, 2026 202.18 Mn
Dec 31, 2025 238.42 Mn
Sep 30, 2025 246.33 Mn
Jun 30, 2025 445.86 Mn
Mar 31, 2025 493.63 Mn
Dec 31, 2024 484.62 Mn
Sep 30, 2024 453.81 Mn
Jun 30, 2024 404.23 Mn
Mar 31, 2024 325.89 Mn
Dec 31, 2023 278.58 Mn
Sep 30, 2023 235.19 Mn
Jun 30, 2023 220.77 Mn
Mar 31, 2023 174.00 Mn
Dec 31, 2022 288.65 Mn
Sep 30, 2022 328.73 Mn
Jun 30, 2022 316.39 Mn
Mar 31, 2022 452.19 Mn
Dec 31, 2021 656.41 Mn
Sep 30, 2021 693.86 Mn
API Access

Pacira BioSciences Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PCRX&period=max&api_key=YOUR_API_KEY